Видео ютуба по тегу Pomalidomide

Know Your Myeloma Therapy: Pomalyst (Pomalidomide)
Know Your Myeloma Therapy: Pomalyst (Pomalidomide)
Все о Помалисте (Помалидомиде) при множественной миеломе
Все о Помалисте (Помалидомиде) при множественной миеломе
Dr. Jagannath on Pomalidomide in Multiple Myeloma
Dr. Jagannath on Pomalidomide in Multiple Myeloma
Pomalidomide in Multiple Myeloma
Pomalidomide in Multiple Myeloma
Pomalidomide in multiple myeloma - Video abstract ID 115456
Pomalidomide in multiple myeloma - Video abstract ID 115456
Elotuzumab Plus Pomalidomide and Dexamethasone for Multiple Myeloma
Elotuzumab Plus Pomalidomide and Dexamethasone for Multiple Myeloma
Dr. Sharma on Pomalidomide in Relapsed/Refractory Multiple Myeloma
Dr. Sharma on Pomalidomide in Relapsed/Refractory Multiple Myeloma
The promise of pomalidomide-backbone combinations for R/R multiple myeloma
The promise of pomalidomide-backbone combinations for R/R multiple myeloma
Ixazomib Plus Pomalidomide, Dexamethasone in Relapsed/Refractory Myeloma
Ixazomib Plus Pomalidomide, Dexamethasone in Relapsed/Refractory Myeloma
Pomalidomide In Lenalidomide-Refractory Patients
Pomalidomide In Lenalidomide-Refractory Patients
What impact do Revlimid® (lenalidomide) and Pomalyst® (pomalidomide) have on the bone marrow?
What impact do Revlimid® (lenalidomide) and Pomalyst® (pomalidomide) have on the bone marrow?
Dr. Lonial on Daratumumab Plus Pomalidomide in Multiple Myeloma
Dr. Lonial on Daratumumab Plus Pomalidomide in Multiple Myeloma
Dr. Glaucomflecken Explains: Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia
Dr. Glaucomflecken Explains: Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia
Apollo: pomalidomide plus dexamethasone, with/without daratumumab in R/R MM
Apollo: pomalidomide plus dexamethasone, with/without daratumumab in R/R MM
Myeloma: pomalidomide, bortezomib and dexamethasone
Myeloma: pomalidomide, bortezomib and dexamethasone
Pomalidomide with dexamethasone in relapsed/refractory multiple myeloma with renal impairment
Pomalidomide with dexamethasone in relapsed/refractory multiple myeloma with renal impairment
ASH 2014: Phase I MM-008 study of pomalidomide in myeloma with renal impairment
ASH 2014: Phase I MM-008 study of pomalidomide in myeloma with renal impairment
Using Pomalidomide in Multiple Myeloma
Using Pomalidomide in Multiple Myeloma
Inobrodib in Combination with Pomalidomide and Dexamethasone in Myeloma | Emma Searle, MD | #ASH24
Inobrodib in Combination with Pomalidomide and Dexamethasone in Myeloma | Emma Searle, MD | #ASH24
Pomalidomide and HDAC Inhibitors in Multiple Myeloma
Pomalidomide and HDAC Inhibitors in Multiple Myeloma
Using combination therapies with pomalidomide to overcome lenalidomide refractoriness in myeloma
Using combination therapies with pomalidomide to overcome lenalidomide refractoriness in myeloma
Dr. Siegel on Pomalidomide in Lenalidomide-Refractory Patients With Myeloma
Dr. Siegel on Pomalidomide in Lenalidomide-Refractory Patients With Myeloma
Could the Combo Daratumumab, Pomalidomide, and Dexamethasone Be Used in an Earlier Line of Therapy?
Could the Combo Daratumumab, Pomalidomide, and Dexamethasone Be Used in an Earlier Line of Therapy?
Pomalidomide in Refractory Multiple Myeloma
Pomalidomide in Refractory Multiple Myeloma
Isatuximab Plus Pomalidomide/Low-Dose Dex Vs Pomalidomide/Low-Dose Dex in Pts with RRMM (ICARIA-MM)
Isatuximab Plus Pomalidomide/Low-Dose Dex Vs Pomalidomide/Low-Dose Dex in Pts with RRMM (ICARIA-MM)